Haimai Medical
Suzhou
About Haimai Medical
Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lower extremity atherosclerosis, and coronary heart disease bypass surgery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $14.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: humatrix-medical.com
Industries & Categories
Medical, Therapeutics
Canonical: https://fsome.com/organization/haimai-medical-76440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.